billHR7535Event Thursday, February 12, 2026Analyzed

Second Chance Mental Health Access Act of 2026

Neutral

Summary

HR7535 is an early-stage bill mandating Medicaid coverage for 12 telehealth mental health visits for certain formerly incarcerated individuals under home confinement. It has been referred to the House Committee on Energy and Commerce with no further action. At this procedural stage, no publicly traded companies are directly affected, and no appropriation is authorized.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR7535 is in early-stage referral with no committee action since February 2026.
  • 2.No direct market impact on any publicly traded company at this procedural stage.
  • 3.The bill's scope is narrow (12 visits for a small population) and contains no appropriation.
  • 4.Absent further legislative progress, this is a monitoring item only for retail investors.

Market Implications

No actionable market implications at this time. The bill is procedural and early-stage with no funding authorized. No tickers are affected. Investors should monitor for committee hearings or markups, which would be the first signal of legislative momentum. Without that, this bill has near-zero probability of near-term enactment and zero identifiable revenue impact for any listed company.

Full Analysis

  1. What happened: On February 12, 2026, Representative Foushee (D-NC) introduced HR7535, the 'Second Chance Mental Health Access Act of 2026'. The bill has been referred to the House Committee on Energy and Commerce, where it remains as of today. It is in an early, procedural stage with no hearings, markups, or floor votes scheduled. The bill mandates that state Medicaid plans cover 12 mental health telehealth visits per year for individuals on home confinement who were incarcerated immediately prior. This is a coverage mandate amendment to the Social Security Act.

  2. The money trail: The bill does not authorize or appropriate any specific dollar amount. It creates a coverage requirement under Medicaid, which is a federal-state matching program. The fiscal impact would depend on CMS actuarial estimates and state-specific enrollment, but no funding figure is included in the bill text. Under Rule 1 (Authorization ≠ Appropriation), there is no allocation—this is a policy mandate without a price tag attached.

  3. Structural winners and losers: No publicly traded companies are directly referenced or clearly affected at this stage. The mandate increases potential Medicaid billing volume for mental health telehealth providers, but the target population (formerly incarcerated individuals on home confinement) is a niche, small group relative to overall Medicaid enrollment. General telehealth platforms (like Amwell or Teladoc) could see incremental demand if the bill were enacted, but at this early stage with no committee action, the probability of passage and ultimate market impact is negligible.

  4. Competitive landscape: Mental health telehealth is a competitive space including Teladoc Health ($TDOC), Amwell ($AMWL), and large health system-owned platforms. However, this bill's limited scope means even if enacted, it would represent a small fraction of these companies' revenue. No price history or market data is available to analyze recent trends for this specific bill.

  5. Timeline: The bill must pass through the House Committee on Energy and Commerce, then the full House, then the Senate, then be signed by the President. With only 11 cosponsors (all Democrats) and no Republican support listed, bipartisan passage is uncertain. The 119th Congress runs through January 2027, so there is time but no visible momentum.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Exec OrderApr 30, 2026

Promoting Efficiency, Accountability, and Performance in Federal Contracting

This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.